Evidence map›Paper›PMID 30199482›Full record

Trial reportThe Pediatric infectious disease journal2018

Mobile, Population-wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda.

James Ayieko, Gabriel Chamie, Laura Balzer, Dalsone Kwarisiima, Jane Kabami, Norton Sang, Craig R Cohen, Elizabeth A Bukusi, Tamara D Clark, Albert Plenty and 5 more

Abstract readClinical Trial
In one paragraph

Trial report in The Pediatric infectious disease journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

James AyiekoFrom the Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya.
Gabriel ChamieUniversity of California, San Francisco, California.
Laura BalzerSchool of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts.
Dalsone KwarisiimaCollege of Health Sciences, Makerere University, Kampala, Uganda.
Jane KabamiCollege of Health Sciences, Makerere University, Kampala, Uganda.
Norton SangFrom the Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya.
Craig R CohenUniversity of California, San Francisco, California.
Elizabeth A BukusiFrom the Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya.
Tamara D ClarkUniversity of California, San Francisco, California.
Albert PlentyUniversity of California, San Francisco, California.
Edwin D CharleboisUniversity of California, San Francisco, California.
Maya PetersenSchool of Public Health, University of California, Berkeley, California.
Moses KamyaCollege of Health Sciences, Makerere University, Kampala, Uganda.
Diane V HavlirUniversity of California, San Francisco, California.
Theodore RuelUniversity of California, San Francisco, California.
University of California, San Francisco · USKenya Medical Research Institute · KEMakerere University · UGUniversity of California, Berkeley · USUniversity of Massachusetts Amherst · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)U01AI099959 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2012 to 2016
$39.7M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
NIAID NIH HHS U01 AI068636NIAID NIH HHS U01 AI099959NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069496PEPFAR
6 · The paper itself

Abstract

Efficient ways to identify children with HIV in the context of universal test-and-treat policies are needed. We evaluated a hybrid testing strategy combining mobile community and home-based HIV testing in 87,700 children across 32 rural communities in 2 East African countries. This approach resulted in 81% testing coverage of at-risk children and doubled the number of children diagnosed with HIV.

Indexed as

ChildChild, PreschoolFemaleHIV InfectionsHumansKenyaMaleMass ScreeningProgram EvaluationRural PopulationUganda

Identifiers

PMID30199482
PMCPMC6226337
OpenAlexW2889995230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.